Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation

被引:0
作者
Wils, Leon J. [1 ,2 ,3 ,4 ,5 ]
Buijze, Marijke [2 ,5 ]
Stigter-van Walsum, Marijke [2 ,5 ]
Brink, Arjen [2 ,5 ]
van Kempen, Britt E. [2 ,5 ]
Peferoen, Laura [3 ]
Brouns, Elisabeth R. [1 ,4 ]
de Visscher, Jan G. A. M. [1 ,4 ]
van der Meij, Erik H. [1 ,4 ]
Bloemena, Elisabeth [1 ,2 ,4 ,5 ]
Poell, Jos B. [2 ,5 ]
Brakenhoff, Ruud H. [2 ,5 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam UMC Locat, Oral & Maxillofacial Surg & Oral Pathol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC Locat, Otolaryngol & Head & Neck Surg, NL-1081 HV Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam UMC Locat, Pathol, NL-1081 HV Amsterdam, Netherlands
[4] Acad Ctr Dent Amsterdam ACTA, NL-1081 LA Amsterdam, Netherlands
[5] Canc Ctr Amsterdam CCA, Canc Biol & Immunol, NL-1081 HV Amsterdam, Netherlands
关键词
oral diseases; oral leukoplakia; oral squamous cell carcinoma; malignant transformation; CRISPR/Cas9; cell culture models; small molecule inhibitors; genetic engineering; GENETICALLY ALTERED FIELDS; KINASE; INHIBITOR; NECK-CANCER; DOUBLE-BLIND; CELL-LINES; TERT GENE; PHASE-I; HEAD; LEUKOPLAKIA; MUTATIONS;
D O I
10.3390/cells13080710
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Precancerous cells in the oral cavity may appear as oral potentially malignant disorders, but they may also present as dysplasia without visual manifestation in tumor-adjacent tissue. As it is currently not possible to prevent the malignant transformation of these oral precancers, new treatments are urgently awaited. Here, we generated precancer culture models using a previously established method for the generation of oral keratinocyte cultures and incorporated CRISPR/Cas9 editing. The generated cell lines were used to investigate the efficacy of a set of small molecule inhibitors. Tumor-adjacent mucosa and oral leukoplakia biopsies were cultured and genetically characterized. Mutations were introduced in CDKN2A and TP53 using CRISPR/Cas9 and combined with the ectopic activation of telomerase to generate cell lines with prolonged proliferation. The method was tested in normal oral keratinocytes and tumor-adjacent biopsies and subsequently applied to a large set of oral leukoplakia biopsies. Finally, a subset of the immortalized cell lines was used to assess the efficacy of a set of small molecule inhibitors. Culturing and genomic engineering was highly efficient for normal and tumor-adjacent oral keratinocytes, but success rates in oral leukoplakia were remarkably low. Knock-out of CDKN2A in combination with either the activation of telomerase or knock-out of TP53 seemed a prerequisite for immortalization. Prolonged culturing was accompanied by additional genetic aberrations in these cultures. The generated cell lines were more sensitive than normal keratinocytes to small molecule inhibitors of previously identified targets. In conclusion, while very effective for normal keratinocytes and tumor-adjacent biopsies, the success rate of oral leukoplakia cell culturing methods was very low. Genomic engineering enabled the prolonged culturing of OL-derived keratinocytes but was associated with acquired genetic changes. Further studies are required to assess to what extent the immortalized cultures faithfully represent characteristics of the cells in vivo.
引用
收藏
页数:25
相关论文
共 96 条
[1]   Systematic analysis of telomere length and somatic alterations in 31 cancer types [J].
Barthel, Floris P. ;
Wei, Wei ;
Tang, Ming ;
Martinez-Ledesma, Emmanuel ;
Hu, Xin ;
Amin, Samirkumar B. ;
Akdemir, Kadir C. ;
Seth, Sahil ;
Song, Xingzhi ;
Wang, Qianghu ;
Lichtenberg, Tara ;
Hu, Jian ;
Zhang, Jianhua ;
Zheng, Siyuan ;
Verhaak, Roel G. W. .
NATURE GENETICS, 2017, 49 (03) :349-357
[2]   Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients [J].
Brouns, E. R. E. A. ;
Baart, J. A. ;
Karagozoglu, K. H. ;
Aartman, I. H. A. ;
Bloemena, E. ;
van der Waal, I. .
ORAL DISEASES, 2014, 20 (03) :e19-e24
[3]  
Califano JA, 2012, J CLIN ONCOL, V30
[4]   Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions [J].
Cesare, Anthony J. ;
Kaul, Zeenia ;
Cohen, Scott B. ;
Napier, Christine E. ;
Pickett, Hilda A. ;
Neumann, Axel A. ;
Reddel, Roger R. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (12) :1244-U59
[5]   Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma [J].
Chang, Kai-Ping ;
Wang, Chun-I ;
Pickering, Curtis R. ;
Huang, Yenlin ;
Tsai, Chi-Neu ;
Tsang, Ngan-Ming ;
Kao, Huang-Kai ;
Cheng, Ming-Huei ;
Myers, Jeffrey N. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (06) :1131-1137
[6]   Topical agents for oral cancer chemoprevention: A systematic review of the literature [J].
Chau, Lucy ;
Jabara, Justin T. ;
Lai, Wanda ;
Svider, Peter F. ;
Warner, Blake M. ;
Lin, Ho-Sheng ;
Raza, S. Naweed ;
Fribley, Andrew M. .
ORAL ONCOLOGY, 2017, 67 :153-159
[7]   Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma [J].
Chen, Yu-Jen ;
Hakin-Smith, Vicky ;
Teo, Mario ;
Xinarianos, George E. ;
Jellinek, David A. ;
Carroll, Thomas ;
McDowell, David ;
MacFarlane, Martin R. ;
Boet, Ronald ;
Baguley, Bruce C. ;
Braithwaite, Antony W. ;
Reddel, Roger R. ;
Royds, Janice A. .
CANCER RESEARCH, 2006, 66 (13) :6473-6476
[8]   Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma [J].
Chera, Bhishamjit S. ;
Sheth, Siddharth H. ;
Patel, Shetal A. ;
Goldin, Dan ;
Douglas, Kathe E. ;
Green, Rebecca L. ;
Shen, Colette J. ;
Gupta, Gaorav P. ;
Moore, Dominic T. ;
Grilley Olson, Juneko E. ;
Weiss, Jared M. .
CANCER, 2021, 127 (23) :4447-4454
[9]   Three-Dimensional Cell Culture Models to Investigate Oral Carcinogenesis: A Scoping Review [J].
Chitturi Suryaprakash, Ravi Teja ;
Kujan, Omar ;
Shearston, Kate ;
Farah, Camile S. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) :1-17
[10]   Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples [J].
Cibulskis, Kristian ;
Lawrence, Michael S. ;
Carter, Scott L. ;
Sivachenko, Andrey ;
Jaffe, David ;
Sougnez, Carrie ;
Gabriel, Stacey ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :213-219